Healthcare
Onco-Innovations Advances PNKP Inhibitor ONC010 as Emerging DDR Therapy
Onco-Innovations Ltd. is developing ONC010, a nanoparticle-encapsulated PNKP inhibitor targeting DNA repair pathways, positioning itself in the DDR therapy market with AI-driven precision oncology capabilities.
Grapes May Support Skin Health at Genetic Level, Study Finds
A new study suggests that consuming grapes can change gene expression in human skin, supporting healthier and more resilient skin, highlighting the importance of diet in skin care.
Mental Health Practices Adapt to Rising Demand for LGBTQIA2S+ Affirming Therapy
Rising Sun Therapy & Wellness expands trauma-informed and identity-aware services to meet the growing need for inclusive mental health care for LGBTQIA2S+ individuals, couples, and families.
Sandgate Family Dental Formally Adds Dental Bridge Assessments to Tooth Replacement Consultations
Sandgate Family Dental now offers dental bridge assessments as part of its tooth replacement consultations, giving North Brisbane bayside residents a clearer comparison of options like bridges, implants, and dentures in one visit.
Southwest Oral Surgical Arts Expands to South St. George, Bringing Specialist Care Closer to Residents
The new South St. George location of Southwest Oral Surgical Arts provides convenient access to oral surgery, periodontal treatment, and dental implants for residents on the south side of the city, reducing travel time for multiple-appointment specialty care.
Study Links Breast Implant Biofilms to Chronic Inflammation and BII Symptoms
A 2024 peer-reviewed study published in MDPI's Microorganisms journal identifies bacterial biofilms on breast implants as a driver of chronic inflammation and systemic symptoms associated with Breast Implant Illness (BII), offering a clinical framework for explant surgery.
Whitfield's Holistic Mommy Makeover Offers Natural Alternative for Breast Implant Illness Patients
Dr. Robert Whitfield introduces a holistic mommy makeover that uses fat transfer breast augmentation and body contouring, providing a natural option for women with breast implant illness.
Colorado Springs Practice Integrates Biological, Minimally Invasive, and Cosmetic Dentistry
Dental Health and Wellness now offers a unified approach combining biological, minimally invasive, and cosmetic dentistry in Colorado Springs, reflecting a shift toward whole-body oral care.
Onco-Innovations Advances Manufacturing Process for Cancer Drug Candidate ONC010
Onco-Innovations Limited has initiated process development and scale-up for ONC010's active ingredient, a key step toward regulatory studies and clinical trials.
Optimi Health Completes First Psilocybin Export to UK for Phase 2 Trial
Optimi Health Corp. has exported naturally derived psilocybin to the UK for a planned Phase 2 clinical trial, marking a milestone in international psychedelic drug distribution.
Earth Science Tech Reports Fiscal 2026 Growth and Debt-Free Expansion Across Health Subsidiaries
Earth Science Tech highlighted fiscal 2026 achievements including expansion of Mister Meds, turnaround of DOConsultation and Villas Health, and revenue growth at Peaks surpassing $2 million, all without adding debt, signaling strong financial discipline and strategic progress.
Maison Luxe Begins Due Diligence on Two Health and Wellness Acquisition Targets
Maison Luxe, Inc. (OTC: MASN) has initiated formal due diligence on two confidential health and wellness companies, advancing its strategy to consolidate in a fragmented $5 trillion global market.
Voyageur Pharmaceuticals Submits Permit Application for Barite Project, Aiming to Become North American Supplier of Pharmaceutical Barium Contrast Agents
Voyageur Pharmaceuticals has submitted a multi-year exploration permit application for its Frances Creek barite project in British Columbia, which could position the company as a secure North American source of pharmaceutical-grade barium contrast products.
Low Blood Pressure Shows Strongest Link to Alzheimer's Risk in New Analysis of Nearly 800,000 Adults
A new study in the Journal of the American Heart Association finds that hypotension is most strongly associated with Alzheimer's disease among several cardiovascular conditions, with stronger effects in Black and Hispanic adults, suggesting shared biological roots.
Carmed Pharmaceuticals Publishes Second Peer-Reviewed Study of Its Carvacrol-Based Formulations
Carmed Pharmaceuticals highlights a new peer-reviewed study on its formulations Vacrol® and S-Mix® in the journal Antioxidants, underscoring its commitment to scientific research as it expands into the U.S. market.
Quantum BioPharma Completes Phase 1 Trial for Multiple Sclerosis Therapy Lucid-MS
Quantum BioPharma announces completion of Phase 1 clinical studies for Lucid-MS, a therapy targeting myelin repair in multiple sclerosis, and submission of an IND application to the FDA.
New Guideline Redefines Weight as Key Risk Factor in Cardiovascular-Kidney-Metabolic Syndrome
The first-ever clinical guideline for cardiovascular-kidney-metabolic syndrome, issued by the American Heart Association and American College of Cardiology, reframes excess weight as a primary driver of interconnected heart, kidney, and metabolic conditions, urging earlier prevention-focused conversations and coordinated care.
First-Ever Guideline on Cardiovascular-Kidney-Metabolic Syndrome Issued
The American Heart Association and the American College of Cardiology released the first clinical practice guideline on cardiovascular-kidney-metabolic (CKM) syndrome, emphasizing early screening and coordinated care to address interconnected heart, kidney, and metabolic conditions affecting nearly 90% of U.S. adults.
Aptevo and Niowave Partner to Advance Radiopharmaceutical Cancer Therapies
Aptevo Therapeutics and Niowave Inc. have formed a 50/50 strategic collaboration to develop up to three radiopharmaceutical oncology programs, combining Aptevo's targeting platforms with Niowave's isotope supply capabilities to address a $17 billion market.
Hospitals Tackle Health Care Access and Affordability Amid Rising Public Concern
Hospitals are taking proactive steps to address health care access and affordability as public concern reaches unprecedented levels, according to the American Hospital Association.
LataMed AI Evaluates Expansion into Fitness and Wellness Markets with AI Health Agent Deployment
LataMed AI Corp. is exploring opportunities to deploy its AI health platforms into fitness and wellness environments as part of its broader healthcare technology growth strategy, potentially expanding use cases for its digital health solutions.
PhillComm Global Adds Personal Security Platform Bond and Mental Health AI Startup Klarify to Client Roster
PhillComm Global expands its portfolio with Bond, a preventative personal security platform, and Klarify, an AI operating system for mental health providers, addressing systemic challenges in personal safety and healthcare administration.
Rejuvenate Bio and Eisana Health Win Top Honors at Superpowers for Good Live Pitch
Two companies, Rejuvenate Bio and Eisana Health, won top awards at the Superpowers for Good Live Pitch event, highlighting innovative approaches to age-related diseases and cancer treatment side effects.
Radioactive Collagen Tiles Reduce Brain Cancer Recurrence in Clinical Trial
A clinical trial found that placing radioactive collagen tiles into the brain cavity during tumor removal dramatically cuts recurrence and extends survival, offering new hope for brain cancer treatment.
Regentis Biomaterials Set to Begin European Surgeon Training for GelrinC Cartilage Implant
Regentis Biomaterials plans to commence surgeon training activities in Q3 2026 to support the commercial rollout of its CE Mark-approved GelrinC treatment for knee cartilage lesions, addressing a significant unmet need in Europe.
Redwood AI's AI-Powered Chemistry Platform Targets Drug Discovery and Defense Markets
Redwood AI is developing a proprietary AI platform for drug discovery and chemical analysis, positioning itself across pharmaceutical, defense, and public safety markets through research collaborations and government-supported initiatives.
Quantum BioPharma Advances Multiple Sclerosis Therapy with LUCID-MS Program, Completes Phase 1 Trials
Quantum BioPharma has completed Phase 1 clinical studies for LUCID-MS, a therapy targeting myelin repair in multiple sclerosis, and filed an IND with the FDA, addressing the critical unmet need for neuroprotective treatments.
CNS Pharmaceuticals Secures Oversubscribed $22.5 Million Financing to Fuel Growth Strategy
CNS Pharmaceuticals highlights its oversubscribed $22.5 million financing and strategic reset in a virtual investor presentation, positioning the company to pursue transformational opportunities and create shareholder value.
TransCode Therapeutics to Host R&D Webcast as It Advances Phase 2a Trial for Colorectal Cancer
TransCode Therapeutics will provide strategic and clinical updates during its first live R&D webcast, anchored by its Phase 2a trial of TTX-MC138 in circulating tumor DNA-positive colorectal cancer, highlighting progress in RNA-based oncology treatments.
Oncotelic Therapeutics to Showcase AI Drug Discovery Platform at Qdrant Vector Space Day 2026
Oncotelic Therapeutics will present its proprietary PDAOAI platform at Qdrant Vector Space Day 2026, highlighting how it accelerated two drug candidates from concept to investigational new drug filings in under two years, significantly reducing time and cost.